RANKL and its cognate receptor RANK are crucial regulators of bone metabolism in physiological as well as in pathological conditions. Here we go through the works that unveiled the paramount role of this signaling pathway. We focus on the RANKL cytokine, whose alterations are responsible for rare and common bone diseases. We describe recent insights on the regulation of RANKL expression, which provide new hints for the pharmacological regulation of this molecule. Based on the multiple functions exerted by RANKL (within and outside the bone tissue), we advise caution regarding the potential unintended consequences of its inhibition.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1152/physiol.00031.2024 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!